Cohort study: Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers.

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study – American Journal of Obstetrics and Gynecology

Commentary on Twitter

For #BRCA1 mutation carriers, longer duration of oral contraceptive use (>10 yr) is associated with a greater reduction in #OvarianCancer risk, and the protection is long term. https://t.co/HrrutgaYKX

— Anna Chichura, MD (@AnnaChichuraMD) July 3, 2021